Maintenance fees coming due
101 maintenance fees come due in the 12 months from Nov 19, 2026, the next on Dec 2, 2026. Unpaid by Jun 2, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,044,553 | Apparatus for Injecting a Pharmaceutical with Automatic Syringe Retraction Following Injection In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | Eli Lilly and Company | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 10,314,981 | Thermal Locking Mechanism for a Medication Delivery Device In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Eli Lilly and Company | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 9,056,844 | 4-Substituted-3-Benzyloxy-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS In force Fee due Dec 16, 2026 Lapses if unpaid Jun 16, 2027 · High confidence | Eli Lilly and Company | In force | Dec 16, 2026 | Jun 16, 2027 | High confidence | |
| US 10,323,019 | Pyrazolylaminobenzimidazole Derivatives as Jak Inhibitors In force Fee due Dec 18, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | Eli Lilly and Company | In force | Dec 18, 2026 | Jun 21, 2027 | High confidence | |
| US 9,060,927 | Insulin Formulations for Rapid Uptake In force Fee due Dec 23, 2026 Lapses if unpaid Jun 23, 2027 · High confidence | Eli Lilly and Company | In force | Dec 23, 2026 | Jun 23, 2027 | High confidence | |
| US 9,067,920 | Compounds Useful for Inhibiting Chk1 In force Fee due Dec 30, 2026 Lapses if unpaid Jun 30, 2027 · High confidence | Eli Lilly and Company | In force | Dec 30, 2026 | Jun 30, 2027 | High confidence | |
| US 9,073,901 | Novel DGAT2 Inhibitors In force Fee due Jan 7, 2027 Lapses if unpaid Jul 7, 2027 · High confidence | Eli Lilly and Company | In force | Jan 7, 2027 | Jul 7, 2027 | High confidence | |
| US 9,073,991 | CGRP Antibodies In force Fee due Jan 7, 2027 Lapses if unpaid Jul 7, 2027 · High confidence | Eli Lilly and Company | In force | Jan 7, 2027 | Jul 7, 2027 | High confidence | |
| US 10,344,018 | Pyrazolylaminobenzimidazole Derivatives as Jak Inhibitors In force Fee due Jan 9, 2027 Lapses if unpaid Jul 9, 2027 · High confidence | Eli Lilly and Company | In force | Jan 9, 2027 | Jul 9, 2027 | High confidence | |
| US 11,697,647 | Ret Kinase Inhibitors In force Fee due Jan 11, 2027 Lapses if unpaid Jul 12, 2027 · High confidence | Eli Lilly and Company | In force | Jan 11, 2027 | Jul 12, 2027 | High confidence | |
| 91 more maintenance fees coming due in the 12 months from Nov 19, 2026 · Pro | |||||||
10 of 101 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.